Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank71
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

Percentile
P71
Within normal range
vs 2Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$7.29M-94.1%
2024$124.00M+1052.9%
2023$10.76M-
2022$0.00-
2021$0.00-
2020$0.00-100.0%
2019$8.12M+749.7%
2018$956000.00+0.4%
2017$952000.00-2.7%
2016$978000.00-